Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Int J Behav Med. 2019 Dec;26(6):600–607. doi: 10.1007/s12529-019-09826-y

Table 1.

Demographic and Clinical Characteristics of the Sample

No COPD (n=31) COPD (n=53)
Demographics Mean (SD) N (%) Mean (SD) N (%) Test Statistic t or X2 (p value)

Age (years) 66.1 (6.6) 70.3 (6.5) t = −2.81 (0.007)
Sex (female) 14 (45.2) 22 (41.5) X2 =0.11 (0.744)
Years of Education 14.5 (2.2) 13.8 (2.2) t = 1.34 (0.183)
Estimated Premorbid IQ (WRAT 4 Standard Score)1 99.9 (9.3) 101.7 (5.4) t = −1.05 (0.297)
MMSE II Raw Score 28.5 (1.6) 27.8 (1.5) t = 1.98 (0.051)
MMSE II Raw Score ≤ 23 1 (3.2) 1 (1.9)
Smoking History (Pack-years) 37.7 (22.3) 61.2 (36.4) t = −3.66 (<.001)
Years Since Smoking Cessation 22.9 (13.7) 14.0 (10.9) t = 3.30 (0.001)
Obstructive Sleep Apnea (Yes) 12 (38.7) 12 (22.6) X2 =2.47 (0.116)
Depression and Anxiety (HADS score)2 5.0 (3.4) 7.3 (5.4) t = −2.42 (0.018)
Post-Bronchodilator Spirometry
FEV1/FVC (%)3 77.9 (5.4) 51.3 (13.0) t =13.13 (<.001)
FEV1 % Predicted4 91.8 (18.1) 51.0 (19.3) t =9.55 (<.001)
Severity of Airflow Limitation
 No COPD (GOLD 0)5 --- ---
 Mild to Moderate COPD (GOLD 1-2) --- 29 (54.7)
 Severe to Very Severe COPD (GOLD 3-4) --- 24 (45.3)

1

WRAT-4: Wide Range Achievement Test – Fourth Edition

2

HADS: Hospital Anxiety and Depression Scale

3

FEV1/FVC: Forced expiratory volume in one second (FEV1) over forced vital capacity (FVC)

4

FEV1 % Predicted: Forced expiratory volume in one second divided by the predicted value times 100

5

GOLD: Global Initiative for Chronic Obstructive Lung Disease